For more information visit: For our latest "Buzz on the Street" Show featuring Nemaura Medical, Inc. proBEAT(TM) comprises a non-invasive glucose monitor and a digital healthcare subscription service and is due to be launched in the U.S. Nemaura has also submitted a PMA application for sugarBEAT® to the U.S. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse and prevent the onset of diabetes. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, and proBEAT(TM). Nemaura expects that proBEATTM will appeal to a broad range of adults encompassing pre-diabetics and Type 2 diabetics, numbering 88 million and 26 million people, respectively, according to the American Diabetes Association, as well as those seeking to lose weight and/or seeking a healthier lifestyle.Ībout Nemaura Medical, Inc.: Nemaura Medical Inc. proBEAT(TM) is intended to be sold directly to consumers, to healthcare insurers, and to corporate clients. The aim is to empower users with knowledge of factors that could affect their blood glucose levels. proBEAT(TM) is a wearable non-invasive glucose monitor designed to gather big data about the multitude of factors that affect glucose levels based on which predictive algorithms and artificial intelligence-based feedback and prompts can be provided to users. and other global territories with its proBEAT(TM) product offering. Nemaura entered into the letter of intent to augment and fast-track its foray into the U.S.
The Company believes these features could form a strong complement to the proBEAT(TM) subscription service Nemaura plans to offer in the U.S. The program is delivered using Hollywood level animation deploying creative user engagement strategies, with a unique program structure aimed at maintaining muscle mass and enhancing metabolism to improve overall health and prevent the regaining of weight. Healthimation is commercialising an application-based diabetes prevention program that has been developed over a period of over 12 years and is supported with clinical data that has been widely published in scientific journal articles. (NASDAQ: NMRD) announced last month that, "it has entered into a letter of intent with Healthimation, LLC ("Healthimation") relating to a possible acquisition of the Healthimation business by Nemaura. Hearables also have the potential to match, or even exceed, the performance of smartwatches when it comes to providing health monitoring services." Smart earwear, or hearables, has become a more prominent category with the emergence of devices that incorporate voice-activated virtual assistants such as Apple's Siri and Google's Assistant. According to GlobalData Analyst, Ed Thomas, "The wearable tech theme incorporates more than just wrist-worn devices. This is also reinforced by the fact that wearable devices are expected to become significantly smarter. The recent pandemic, which has put a heavy toll on our economy and pushed the healthcare system into a severe scarcity problem, further illustrates the importance of wearable remote monitoring devices. (NASDAQ: NMRD), Abbott Laboratories (NYSE: ABT), Masimo Corporation (NASDAQ: MASI), Livongo Health, Inc.
Overall, the global wearable medical device market size is expected to reach USD 29.6 Billion by 2026 and expand at a Compound Annual Growth Rate (CAGR) of 17.7%, according to Transparency Market Research. The most commonly measured data include vital signs such as heart rate, blood pressure, and body temperature, as well as blood oxygen saturation and glucose levels. Wearable technologies allow for constant and remote monitoring of biochemical parameters, as well as human physical activities and behaviors. Wearables, in particular, are a new trend that has been evolving in the medical technology sector in recent years. 11, 2020 /PRNewswire/ - Some of the most promising, high-growth-opportunity segments in the medical device market by application include surgical and infection control devices, general medical devices, cardiovascular devices, orthopedic devices and wearable monitoring healthcare technologies.
0 kommentar(er)
